While cervical cancer has been the primary health concern linked to Human Papilloma Virus (HPV) infections, medical experts are now shedding light on another cancer with ties to this widespread sexually transmitted infection – oropharyngeal cancer. New cases of mouth and throat cancers connected to HPV have been escalating at an alarming rate over the past few decades. This article explores the troubling rise in HPV-related oropharyngeal cancer, including the signs everyone should know.
Certain strains of HPV have long been established as the principal cause of cervical cancers in women. However, research in recent years confirms this pervasive virus can also contribute to cell changes and tumor formation in the oropharynx – the part of the throat including the soft palate, base of the tongue and tonsils. Data shows the percentage of head and neck cancers involving the oropharynx and testing positive for HPV DNA has climbed significantly since the 1990s. In the United States alone, HPV-positive oropharyngeal cancers now account for more than 70% of all such malignancies according to the Centers for Disease Control and Prevention (CDC).
While cigarette smoking and heavy drinking were previously major risk factors for oral and throat cancers, HPV is surpassing these lifestyle choices as the primary culprit in many parts of the world. Early detection is key to improving treatment outcomes as HPV-positive tumors tend to respond better to chemotherapy and radiation. Seeking prompt medical evaluation for persistent sore throat, ear pain, lumps in the neck, or difficulty swallowing that lasts over two weeks can help identify oropharyngeal cancer at an early, more curable stage. Preventive measures involve practicing safe sex and getting recommended HPV vaccinations. Spreading knowledge about this evolving cancer risk associated with HPV may help reduce case numbers going forward.
